SEC Comment Letter for Ernexa Therapeutics Inc. (ERNA, ERNAW) (CIK 0000748592) (ERNA) — Apr 15, 2016
Ernexa Therapeutics Inc. (ERNA, ERNAW) (CIK 0000748592)
Date: April 15, 2016 · CIK: 0000748592 · Accession: 0000000000-16-072350
AI Filing Summary & Sentiment
Show Raw Text
Mail Stop 3720 April 15 , 2016 Ram Krishnan Chief Executive Officer NTN Buzztime, Inc. 2231 Rutherford Road, Suite 200 Carlsbad, California Re: NTN Buzztime, Inc. Preliminary Proxy on Schedule 14A Filed April 7, 2016 File No. 001 -11460 Dear Mr. Krishnan : We have completed our review of your filing. We remind you that our comment or the changes to disclosure in response to our comment do not foreclose the Commission from taking any action with respect to the company or the filing and the company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. We urge all persons who are responsible for the accuracy and adequacy of the disclosure in the filing to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely, /s/ Celeste M. Murphy for Larry Spirgel Assistant Direc tor AD Office 11 – Telecommunications